A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy
Public ClinicalTrials.gov record NCT06346340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy
Study identification
- NCT ID
- NCT06346340
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Interventions
- Miebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 29, 2024
- Primary completion
- Feb 23, 2025
- Completion
- Feb 23, 2025
- Last update posted
- Apr 14, 2025
2024 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 105 | Laguna Hills | California | 92655 | — |
| Site 102 | Petaluma | California | 92954 | — |
| Site 109 | Sacramento | California | 94206 | — |
| Site 111 | Grand Junction | Colorado | 81501 | — |
| Site 103 | Largo | Florida | 33770 | — |
| Site 106 | Oak Lawn | Illinois | 60453 | — |
| Site 108 | Alexandria | Minnesota | 56308 | — |
| Site 104 | St Louis | Missouri | 63131 | — |
| Site 101 | Somersworth | New Hampshire | 03878 | — |
| Site 107 | Sioux Falls | South Dakota | 57108 | — |
| Site 110 | San Antonio | Texas | 78229 | — |
| Site 112 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06346340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2025 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06346340 live on ClinicalTrials.gov.